$BLLN

Atay Oguzhan sold $1.5M of BLLN (indirect holdings)

Atay Oguzhan (Chairman and CEO) sold 12,500 indirectly-held shares of BillionToOne, Inc. (BLLN) at an average of $122.05 ($118.81–$124.74, $1.53M total) across 14 trades on 2026-07-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Atay Oguzhan
Published Jul 8, 2026, 11:06 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 8, 2026, 11:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$BLLN
Neutral
medium confidence
Mentioned
$BLLN
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BLLNNeutralLow
01

Why it matters

Traders may briefly reassess sentiment due to insider selling, but the pre-arranged nature reduces interpretive weight versus an unplanned sale.

02

Market read

A $1.53M open-market insider sale under 10b5-1 is disclosed, likely causing only marginal sentiment impact absent other catalysts.

03

What to watch

The article notes indirect holdings and multiple small trades; without context on total insider ownership changes over time, the signal is limited.

Relevance 5/10Novelty 4/10Timing: today’s SEC Form 4 disclosure, after-hours filing timestamp

Background

The filing is an SEC Form 4 insider transaction by the company’s Chairman and CEO, explicitly tied to a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$BLLNNeutralMedium confidence
Context

BillionToOne CEO Atay Oguzhan sold $1.53M of BLLN shares via a Rule 10b5-1 plan, filing a Form 4 on July 8.

Expected impact

Likely minimal, though it can add short-term overhang if traders interpret it as supply or confidence signal.

Evidence & confidence

The filing specifies an open-market sale and confirms a pre-arranged 10b5-1 plan; the article provides no new operational, financial, or regulatory catalyst.

Market effects

No sector-level read-across; this is company-specific insider transaction reporting.

None indicated.

None indicated.

Counterpoint

10b5-1 sales are often mechanical and may reflect diversification or liquidity needs rather than bearish expectations.

Key entities

  • BillionToOne, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Atay Oguzhan

    Chairman and CEO who executed the open-market sale under a 10b5-1 plan.

Related articles

$BLLNMedAI 8/10

BillionToOne Stock (BLLN) Falls After Hours: Here's What's Driving the Move - BillionToOne (NASDAQ:BLLN)

BillionToOne (NASDAQ:BLLN) shares fell 28.12% in after-hours after reporting Q2 results. For the quarter ended June 30, 2026, revenue rose to $109.4M from $66.6M, net income was $8.1M ($0.15/share), and gross margin improved to 70%. The company kept 2026 revenue guidance of $450M to $465M and plans Unity Fetal Risk Screen (Aug. 17) and Northstar Origin (Sept. 1) launches.

$BLLNMedAI 8/10

Billiontoone (BLLN) – Research Analysts’ Recent Ratings Updates

BillionToOne (NASDAQ: BLLN) saw multiple analyst rating and target changes. Weiss Ratings upgraded BLLN to “sell (d+)” (from “sell (d)”) on 5/15 and reaffirmed “sell (d)” on 5/1. Guggenheim raised its target to $120 (from $100) and kept a “buy” on 5/13. JPMorgan lifted its target to $125 and maintained “overweight” on 5/7. BTIG cut its target to $130 (from $140) while keeping “buy” on 5/7.